Activity ID
14328Expires
June 18, 2028Format Type
EnduringCME Credit
1Fee
$0CME Provider: Massachusetts Medical Society
Description of CME Course
Glucagon-like peptide-1 (GLP-1) has emerged as a key regulator in metabolic health, with profound implications for diabetes management, weight loss, and cardiovascular protection. The 135th Annual Shattuck Lecture explores the discovery, physiological role, and therapeutic applications of GLP-1 receptor agonists (GLP-1 RAs). Participants will gain insight into the patient selection criteria, the broader impact of GLP-1 modulation, and potential future applications of GLP-1-based therapies.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
Discuss the history and discovery of GLP-1 and its relevance to metabolic health
Explain the physiologic role of GLP-1 in health and disease
Define patient selection criteria and considerations for prescribing GLP-1 receptor agonists
Evaluate the public health impact of GLP-1 based interventions on disease management and health care outcomes
Describe ongoing research that could expand the role of GLP-1 therapies
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Physician Executives, Physician Scientists, Rural, Urban, VA/Military
